
News|Videos|June 8, 2018
Evolving Use of ICIs and Targeted Tx in NSCLC and SCLC
Author(s)Apar Kishor Ganti, MD, MS
In this video, Apar Ganti, MD, highlights recent advances and studies presented at ASCO 2018 on management of NSCLC and SCLC with ICIs and targeted agents.
Advertisement
In this video, Apar Ganti, MD, highlights recent advances and studies presented at ASCO 2018 on management of NSCLC and SCLC with ICIs and targeted agents.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Top 10 Peer-Reviewed ONCOLOGY Articles Shaping Cancer Care in 2025
2
Oncology On the Go Wrapped: The Top 10 Podcast Episodes of 2025
3
Behind the MATTERHORN Trial of Durvalumab/FLOT in Gastric/GEJ Cancer
4
Addressing Sexual and Gender Minority Care in Oncology
5
































































































